首页 > 市场调查报告书 > 製药

疫苗癌症

市场调查报告书

商品编码

1347587

癌症疫苗市场：2023-2028 年全球行业趋势、份额、规模、增长、机会和预测

Cancer Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年09月04日 | 出版商:

IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

市场概况：

2022年全球癌症疫苗市场规模达到61亿美元。展望未来，IMARC集团预计到2028年市场规模将达到121亿美元，2023-2028年復合年增长率（CAGR）为11.61%。

癌症是由于体内异常细胞不受控制地生长而引起的恶性肿瘤。它可以通过使用各种药物和疫苗来治疗。其中，疫苗大致分为预防性疫苗和治疗性疫苗。预防性癌症疫苗用于消除由肿瘤病毒引起的癌症并预防人乳头瘤病毒 (HPV)，而治疗性疫苗则通过使用肿瘤抗原帮助刺激个体适应性免疫系统。目前，商业上的癌症疫苗有多种类型，例如抗原、树突状细胞和抗独特型。

癌症疫苗市场趋势：

癌症患病率不断上升，特别是由于烟草产品消费的增加和生活方式的不断变化，目前正在推动癌症疫苗市场的增长。据此，一些国家的政府机构为引入新型癌症疫苗而采取的有利倡议，以及在病毒重组癌症疫苗领域的大量资金，进一步促进了这些疫苗在医疗保健领域的广泛采用。与此相一致的是，广泛使用美国食品和药物管理局（US FDA）批准的疫苗，包括人乳头瘤病毒疫苗（HPV）和乙型肝炎疫苗（HBV）来降低某些类型癌症（例如肝癌）的风险，正在为市场增长做出贡献。该市场还受到专注于开发有效和特定癌症治疗方法的快速技术进步的显着推动。其他因素，例如医疗基础设施的改善、易患包括癌症在内的各种慢性疾病的老年人口不断增加，以及消费者对症状和可用治疗方案的认识不断增强，正在为全球市场进一步创造积极的前景。

本报告回答的关键问题：

迄今为止，全球癌症疫苗市场表现如何，未来几年将如何表现？
COVID-19 对全球癌症疫苗市场有何影响？
主要区域市场有哪些？
根据类型划分市场是怎样的？
基于技术的市场细分是什么？
根据指示，市场的细分是什么？
基于最终用户的市场细分是什么？
行业价值链的各个阶段是什么？
该行业的关键驱动因素和挑战是什么？
全球癌症疫苗市场的结构如何？谁是主要参与者？
行业竞争程度如何？

北美
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳大利亚
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉美
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 11 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 12 章：价值链分析

第 13 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 14 章：价格分析

第15章：竞争格局

市场结构
关键参与者
关键参与者简介
- Anixa Biosciences Inc.
- Dendreon Pharmaceuticals LLC
- Dynavax Technologies Corporation
- GSK plc
- Merck & Co. Inc.
- Moderna Inc.
- OSE Immunotherapeutics
- Providence Therapeutics
- Sanofi SA
- UbiVac Inc.
- Vaccitech plc

简介目录图表

Product Code: SR112023A5901

Market Overview:

The global cancer vaccines market size reached US$ 6.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 12.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.61% during 2023-2028.

Cancer is a malignant tumor caused by the uncontrollable growth of abnormal cells in the body. It can be treated through the use of various medications and vaccines. Between these, vaccines are broadly categorized into preventive and therapeutic. Preventive cancer vaccines are deployed for eliminating cancer caused by oncovirus and protecting from human papillomavirus (HPV), whereas therapeutic vaccines aid in stimulating the individual adaptive immune systems by using tumor antigens. At present, cancer vaccines are commercially available in varying types, such as antigen, dendritic cell, and anti-idiotype.

Cancer Vaccines Market Trends:

The increasing prevalence of cancer, especially due to the rising consumption of tobacco-based products and evolving lifestyles is currently driving the cancer vaccines market growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel cancer vaccines, along with extensive fundings in the field of viral recombinant cancer vaccines are further facilitating the widespread adoption of these vaccines in the healthcare sector. In line with this, the extensive utilization of United States Food and Drug Administration (US FDA) approved vaccines, including human papillomavirus vaccine (HPV) and hepatitis B vaccine (HBV) to reduce the risk of certain types of cancer, such as liver cancer, is contributing to the market growth. The market is also significantly driven by rapid technological advancements focusing on the development of effective and specific cancer treatments. Other factors, such as improving healthcare infrastructure, rising geriatric population, who are susceptible to various chronic ailments, including cancer, and growing consumer awareness regarding the symptoms and the available treatment options, are creating a positive outlook for the market further across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, indication and end user.

Breakup by Type:

Preventive Cancer Vaccines

Therapeutic Cancer Vaccines

Breakup by Technology:

Dendritic Cells Cancer Vaccines

Recombinant Cancer Vaccines

Antigen/Adjuvant Cancer Vaccines

Viral Vector and DNA Cancer Vaccines

Whole-cell Cancer Vaccines

Breakup by Indication:

Cervical Cancer

Prostate Cancer

Others

Breakup by End User:

Pediatrics

Adults

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Anixa Biosciences Inc., Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, GSK plc, Merck & Co. Inc., Moderna Inc., OSE Immunotherapeutics, Providence Therapeutics, Sanofi S.A., UbiVac Inc. and Vaccitech plc.

Key Questions Answered in This Report:

How has the global cancer vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cancer vaccines market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cancer vaccines market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cancer Vaccines Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Preventive Cancer Vaccines
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Therapeutic Cancer Vaccines
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Technology

7.1 Dendritic Cells Cancer Vaccines
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Recombinant Cancer Vaccines
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Antigen/Adjuvant Cancer Vaccines
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Viral Vector and DNA Cancer Vaccines
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Whole-cell Cancer Vaccines
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Indication

8.1 Cervical Cancer
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Prostate Cancer
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by End User

9.1 Pediatrics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Adults
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Anixa Biosciences Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
- 15.3.2 Dendreon Pharmaceuticals LLC
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Dynavax Technologies Corporation
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
- 15.3.4 GSK plc
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Merck & Co. Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Moderna Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
- 15.3.7 OSE Immunotherapeutics
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
- 15.3.8 Providence Therapeutics
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Sanofi S.A.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 UbiVac Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
- 15.3.11 Vaccitech plc
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials

简介目录图表

List of Figures

Figure 1: Global: Cancer Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Cancer Vaccines Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Vaccines Market: Breakup by Type (in %), 2022
Figure 5: Global: Cancer Vaccines Market: Breakup by Technology (in %), 2022
Figure 6: Global: Cancer Vaccines Market: Breakup by Indication (in %), 2022
Figure 7: Global: Cancer Vaccines Market: Breakup by End User (in %), 2022
Figure 8: Global: Cancer Vaccines Market: Breakup by Region (in %), 2022
Figure 9: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cancer Vaccines (Preventive Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cancer Vaccines (Therapeutic Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cancer Vaccines (Dendritic Cells Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cancer Vaccines (Recombinant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cancer Vaccines (Antigen/Adjuvant Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cancer Vaccines (Viral Vector and DNA Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cancer Vaccines (Whole-cell Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cancer Vaccines (Cervical Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cancer Vaccines (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cancer Vaccines (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cancer Vaccines (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cancer Vaccines (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cancer Vaccines (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cancer Vaccines (Pediatrics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cancer Vaccines (Pediatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Cancer Vaccines (Adults) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Cancer Vaccines (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: North America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: United States: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: United States: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Canada: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Canada: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia-Pacific: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Asia-Pacific: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: China: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: China: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Japan: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Japan: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: India: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: India: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: South Korea: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: South Korea: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Australia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Australia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Indonesia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Indonesia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Europe: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Europe: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Germany: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Germany: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: France: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: France: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: United Kingdom: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: United Kingdom: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Italy: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Italy: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Spain: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Spain: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Russia: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Russia: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Latin America: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Latin America: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Brazil: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Brazil: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Mexico: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Mexico: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Middle East and Africa: Cancer Vaccines Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Middle East and Africa: Cancer Vaccines Market: Breakup by Country (in %), 2022
Figure 81: Middle East and Africa: Cancer Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Global: Cancer Vaccines Industry: SWOT Analysis
Figure 83: Global: Cancer Vaccines Industry: Value Chain Analysis
Figure 84: Global: Cancer Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer Vaccines Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Vaccines Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Cancer Vaccines Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 4: Global: Cancer Vaccines Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 5: Global: Cancer Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Cancer Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Cancer Vaccines Market: Competitive Structure
Table 8: Global: Cancer Vaccines Market: Key Players

02-2729-4219

+886-2-2729-4219